世界の動物医薬品用フルララネルAPI市場予測2023-2029:純度≧98%、純度<98%

【英語タイトル】Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY2421)・商品コード:MMG23LY2421
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:78
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:化学&材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の動物医薬品用フルララネルAPI市場規模と予測を収録しています。・世界の動物医薬品用フルララネルAPI市場:売上、2018年-2023年、2024年-2029年
・世界の動物医薬品用フルララネルAPI市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の動物医薬品用フルララネルAPI市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「純度≧98%」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

動物医薬品用フルララネルAPIのグローバル主要企業は、Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、動物医薬品用フルララネルAPIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の動物医薬品用フルララネルAPI市場:タイプ別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場:タイプ別市場シェア、2022年
・純度≧98%、純度<98%

世界の動物医薬品用フルララネルAPI市場:用途別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場:用途別市場シェア、2022年
・内服薬、外用薬

世界の動物医薬品用フルララネルAPI市場:地域・国別、2018年-2023年、2024年-2029年
世界の動物医薬品用フルララネルAPI市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における動物医薬品用フルララネルAPIのグローバル売上、2018年-2023年
・主要企業における動物医薬品用フルララネルAPIのグローバル売上シェア、2022年
・主要企業における動物医薬品用フルララネルAPIのグローバル販売量、2018年-2023年
・主要企業における動物医薬品用フルララネルAPIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology

*************************************************************

・調査・分析レポートの概要
動物医薬品用フルララネルAPI市場の定義
市場セグメント
世界の動物医薬品用フルララネルAPI市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の動物医薬品用フルララネルAPI市場規模
世界の動物医薬品用フルララネルAPI市場規模:2022年 VS 2029年
世界の動物医薬品用フルララネルAPI市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの動物医薬品用フルララネルAPIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の動物医薬品用フルララネルAPI製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:純度≧98%、純度<98%
動物医薬品用フルララネルAPIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分:内服薬、外用薬
動物医薬品用フルララネルAPIの用途別グローバル売上・予測

・地域別市場分析
地域別動物医薬品用フルララネルAPI市場規模 2022年と2029年
地域別動物医薬品用フルララネルAPI売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Nissan Chemical、 HIKAL Ltd.、 HuBei Masteam Bio-tech、 Jiangsu Rivocean、 Shaanxi Dideu Group、 Zhejiang Gihi Chemicals、 Hunan Huateng Pharmaceutical、 Taizhou Crene Biotechnology
...

This report aims to provide a comprehensive presentation of the global market for Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient. This report contains market size and forecasts of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in global, including the following market information:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Sales, 2018-2023, 2024-2029, (Tons)
Global top five Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient companies in 2022 (%)
The global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity ≥98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient include Nissan Chemical, HIKAL Ltd., HuBei Masteam Bio-tech, Jiangsu Rivocean, Shaanxi Dideu Group, Zhejiang Gihi Chemicals, Hunan Huateng Pharmaceutical and Taizhou Crene Biotechnology, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Tons)
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2022 (%)
Purity ≥98%
Purity <98% Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Tons) Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2022 (%) Oral Drug External Drug Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Tons) Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues in global market, 2018-2023 (Estimated), ($ millions) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient revenues share in global market, 2022 (%) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales in global market, 2018-2023 (Estimated), (Tons) Key companies Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient sales share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Nissan Chemical HIKAL Ltd. HuBei Masteam Bio-tech Jiangsu Rivocean Shaanxi Dideu Group Zhejiang Gihi Chemicals Hunan Huateng Pharmaceutical Taizhou Crene Biotechnology Outline of Major Chapters: Chapter 1: Introduces the definition of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient, market overview. Chapter 2: Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient market size in revenue and volume. Chapter 3: Detailed analysis of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient capacity by region & country. Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry. Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Overall Market Size
2.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size: 2022 VS 2029
2.2 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales: 2018-2029
3 Company Landscape
3.1 Top Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.2 Top Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies Ranked by Revenue
3.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue by Companies
3.4 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales by Companies
3.5 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Type
3.8 Tier 1, Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market
3.8.1 List of Global Tier 1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
3.8.2 List of Global Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size Markets, 2022 & 2029
4.1.2 Purity ≥98%
4.1.3 Purity <98% 4.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 4.2.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 4.2.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 4.2.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 4.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 4.3.1 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 4.3.2 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 4.3.3 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 4.4 By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2022 & 2029 5.1.2 Oral Drug 5.1.3 External Drug 5.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 5.2.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 5.2.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 5.2.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 5.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 5.3.1 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 5.3.2 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 5.3.3 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 5.4 By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (Manufacturers Selling Prices), 2018-2029 6 Sights by Region 6.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2022 & 2029 6.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue & Forecasts 6.2.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2023 6.2.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2024-2029 6.2.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029 6.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales & Forecasts 6.3.1 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2023 6.3.2 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2024-2029 6.3.3 By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029 6.4 North America 6.4.1 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.4.2 By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.4.3 US Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.4.4 Canada Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.4.5 Mexico Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5 Europe 6.5.1 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.5.2 By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.5.3 Germany Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.4 France Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.5 U.K. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.6 Italy Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.7 Russia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.8 Nordic Countries Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.5.9 Benelux Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6 Asia 6.6.1 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.6.2 By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.6.3 China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.4 Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.5 South Korea Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.6 Southeast Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.6.7 India Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.7 South America 6.7.1 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.7.2 By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.7.3 Brazil Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.7.4 Argentina Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8 Middle East & Africa 6.8.1 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 6.8.2 By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, 2018-2029 6.8.3 Turkey Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.4 Israel Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.5 Saudi Arabia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 6.8.6 UAE Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size, 2018-2029 7 Manufacturers & Brands Profiles 7.1 Nissan Chemical 7.1.1 Nissan Chemical Company Summary 7.1.2 Nissan Chemical Business Overview 7.1.3 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.1.4 Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.1.5 Nissan Chemical Key News & Latest Developments 7.2 HIKAL Ltd. 7.2.1 HIKAL Ltd. Company Summary 7.2.2 HIKAL Ltd. Business Overview 7.2.3 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.2.4 HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.2.5 HIKAL Ltd. Key News & Latest Developments 7.3 HuBei Masteam Bio-tech 7.3.1 HuBei Masteam Bio-tech Company Summary 7.3.2 HuBei Masteam Bio-tech Business Overview 7.3.3 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.3.4 HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.3.5 HuBei Masteam Bio-tech Key News & Latest Developments 7.4 Jiangsu Rivocean 7.4.1 Jiangsu Rivocean Company Summary 7.4.2 Jiangsu Rivocean Business Overview 7.4.3 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.4.4 Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.4.5 Jiangsu Rivocean Key News & Latest Developments 7.5 Shaanxi Dideu Group 7.5.1 Shaanxi Dideu Group Company Summary 7.5.2 Shaanxi Dideu Group Business Overview 7.5.3 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.5.4 Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.5.5 Shaanxi Dideu Group Key News & Latest Developments 7.6 Zhejiang Gihi Chemicals 7.6.1 Zhejiang Gihi Chemicals Company Summary 7.6.2 Zhejiang Gihi Chemicals Business Overview 7.6.3 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.6.4 Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.6.5 Zhejiang Gihi Chemicals Key News & Latest Developments 7.7 Hunan Huateng Pharmaceutical 7.7.1 Hunan Huateng Pharmaceutical Company Summary 7.7.2 Hunan Huateng Pharmaceutical Business Overview 7.7.3 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.7.4 Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.7.5 Hunan Huateng Pharmaceutical Key News & Latest Developments 7.8 Taizhou Crene Biotechnology 7.8.1 Taizhou Crene Biotechnology Company Summary 7.8.2 Taizhou Crene Biotechnology Business Overview 7.8.3 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Major Product Offerings 7.8.4 Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales and Revenue in Global (2018-2023) 7.8.5 Taizhou Crene Biotechnology Key News & Latest Developments 8 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, Analysis 8.1 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity, 2018-2029 8.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity of Key Manufacturers in Global Market 8.3 Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region 9 Key Market Trends, Opportunity, Drivers and Restraints 9.1 Market Opportunities & Trends 9.2 Market Drivers 9.3 Market Restraints 10 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Supply Chain Analysis 10.1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Value Chain 10.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Upstream Market 10.3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Downstream and Clients 10.4 Marketing Channels Analysis 10.4.1 Marketing Channels 10.4.2 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors and Sales Agents in Global 11 Conclusion 12 Appendix 12.1 Note 12.2 Examples of Clients 12.3 Disclaimer

List of Tables
Table 1. Key Players of Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient in Global Market
Table 2. Top Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Share by Companies, 2018-2023
Table 5. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales by Companies, (Tons), 2018-2023
Table 6. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Type
Table 9. List of Global Tier 1 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2018-2023
Table 15. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2024-2029
Table 16. By Application – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2018-2023
Table 20. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2024-2029
Table 21. By Region – Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2018-2023
Table 25. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), 2024-2029
Table 26. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2018-2023
Table 29. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2024-2029
Table 30. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2018-2023
Table 33. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2024-2029
Table 34. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2018-2023
Table 37. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2024-2029
Table 38. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2018-2023
Table 41. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales, (Tons), 2024-2029
Table 46. Nissan Chemical Company Summary
Table 47. Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 48. Nissan Chemical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Nissan Chemical Key News & Latest Developments
Table 50. HIKAL Ltd. Company Summary
Table 51. HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 52. HIKAL Ltd. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. HIKAL Ltd. Key News & Latest Developments
Table 54. HuBei Masteam Bio-tech Company Summary
Table 55. HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 56. HuBei Masteam Bio-tech Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. HuBei Masteam Bio-tech Key News & Latest Developments
Table 58. Jiangsu Rivocean Company Summary
Table 59. Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 60. Jiangsu Rivocean Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 61. Jiangsu Rivocean Key News & Latest Developments
Table 62. Shaanxi Dideu Group Company Summary
Table 63. Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 64. Shaanxi Dideu Group Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 65. Shaanxi Dideu Group Key News & Latest Developments
Table 66. Zhejiang Gihi Chemicals Company Summary
Table 67. Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 68. Zhejiang Gihi Chemicals Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 69. Zhejiang Gihi Chemicals Key News & Latest Developments
Table 70. Hunan Huateng Pharmaceutical Company Summary
Table 71. Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 72. Hunan Huateng Pharmaceutical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 73. Hunan Huateng Pharmaceutical Key News & Latest Developments
Table 74. Taizhou Crene Biotechnology Company Summary
Table 75. Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Product Offerings
Table 76. Taizhou Crene Biotechnology Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 77. Taizhou Crene Biotechnology Key News & Latest Developments
Table 78. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 79. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region, 2018-2023 (Tons)
Table 81. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production by Region, 2024-2029 (Tons)
Table 82. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Opportunities & Trends in Global Market
Table 83. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Drivers in Global Market
Table 84. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Restraints in Global Market
Table 85. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Raw Materials
Table 86. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Raw Materials Suppliers in Global Market
Table 87. Typical Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Downstream
Table 88. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Downstream Clients in Global Market
Table 89. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Segment by Type in 2022
Figure 2. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Segment by Application in 2022
Figure 3. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, 2018-2029 (US$, Mn)
Figure 7. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue in 2022
Figure 9. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 11. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 12. By Type - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 15. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 16. By Application - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 20. By Region - Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 21. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 22. By Country - North America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 23. US Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 28. Germany Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 29. France Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 37. China Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 41. India Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 43. By Country - South America Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 44. Brazil Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Sales Market Share, 2018-2029
Figure 48. Turkey Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Revenue, (US$, Mn), 2018-2029
Figure 52. Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient by Region, 2022 VS 2029
Figure 54. Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の動物医薬品用フルララネルAPI市場予測2023-2029:純度≧98%、純度<98%] (コード:MMG23LY2421)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の動物医薬品用フルララネルAPI市場予測2023-2029:純度≧98%、純度<98%]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆